|
Germain, Ronald N.
As of 2003, served as deputy director of the U.S. National Institutes of Health's Laboratory of Immunology (since 1987).
Collected more than $1.4 million in company consulting fees (1992-2003), plus stock options, including companies that had grants or research agreements with his NIH laboratory, such as Wyeth's Genetics Institute, Mojave Therapeutics, Alexion Pharmaceuticals, Cell Genesys, and MedImmune. (1)
Endnotes:
(1) Willman, David. Stealth Merger: Drug Companies and Government Medical Research. Los Angeles Times, Dec 7, 2003.
|
